Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metabolic effects of paliperidone extended release versus oral olanzapine in patients with schizophrenia: a prospective, randomized, controlled trial.
Schreiner A, Niehaus D, Shuriquie NA, Aadamsoo K, Korcsog P, Salinas R, Theodoropoulou P, Fernández LG, Uçok A, Tessier C, Bergmans P, Hoeben D. Schreiner A, et al. J Clin Psychopharmacol. 2012 Aug;32(4):449-57. doi: 10.1097/JCP.0b013e31825cccad. J Clin Psychopharmacol. 2012. PMID: 22722501 Clinical Trial.
Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics.
Hargarter L, Cherubin P, Bergmans P, Keim S, Rancans E, Bez Y, Parellada E, Carpiniello B, Vidailhet P, Schreiner A. Hargarter L, et al. Among authors: schreiner a. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Apr 3;58:1-7. doi: 10.1016/j.pnpbp.2014.11.006. Epub 2014 Nov 15. Prog Neuropsychopharmacol Biol Psychiatry. 2015. PMID: 25448776 Free article. Clinical Trial.
Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study.
Schreiner A, Caspi A, Bergmans P, Cherubin P, Keim S, Lara E, Pinchuk I, Schuepbach D, Suleman S, Hargarter L. Schreiner A, et al. Psychopharmacology (Berl). 2017 Jan;234(1):3-13. doi: 10.1007/s00213-016-4445-0. Epub 2016 Nov 5. Psychopharmacology (Berl). 2017. PMID: 27815602 Free PMC article.
Paliperidone palmitate in non-acute patients with schizophrenia previously unsuccessfully treated with risperidone long-acting therapy or frequently used conventional depot antipsychotics.
Schreiner A, Bergmans P, Cherubin P, Keim S, Llorca PM, Cosar B, Petralia A, Corrivetti G, Hargarter L. Schreiner A, et al. J Psychopharmacol. 2015 Aug;29(8):910-22. doi: 10.1177/0269881115586284. Epub 2015 May 21. J Psychopharmacol. 2015. PMID: 25999398 Free PMC article. Clinical Trial.
Risperidone in the treatment of acute schizophrenia.
Raedler TJ, Schreiner A, Naber D, Wiedemann K. Raedler TJ, et al. Among authors: schreiner a. J Clin Psychopharmacol. 2004 Jun;24(3):335-8. doi: 10.1097/01.jcp.0000126660.50788.ef. J Clin Psychopharmacol. 2004. PMID: 15118488
374 results